Greetings
Message from
The Organizers
The Organizers
Dear Colleagues;
The 86th Annual meeting of the Japanese Society of Interferon and Cytokine Research (JSICR) will be held as the International Joint Symposium with The Japanese Society of Molecular Cell Biology of Macrophages (MMCB), at the University of Tokyo, Yayoi Auditorium, Japan, on June 9 and 10, 2022.
JSICR derives from The Society for Viral Inhibition Factors established by Dr. Nagano, who discovered interferon, in 1961. This society was reorganized two times, first The Society for Interferon Research, and then The Japanese Society for Interferon and Cytokine Research in 1998. 2022 annual meeting is the 86th time, so the society has a long history of interferon and cytokine research in Japan. This meeting will be co-hosted with MMCB and provide an opportunity to think about the challenges and future directions of both societies.
In this joint meeting, I hope we will deeply discuss the insights into how cytokines and interferons regulate immunity, inflammation, metabolism, and cancer.
Sincerely yours,
Shigeru Kakuta, PhD., DVM.
Chair, The 86th Annual Meeting of the Japanese Society of Interferon & Cytokine Research (JSICR2022)
Laboratory of Biomedical Science,
Graduate School of Agricultural and Life Sciences,
The University of Tokyo
Graduate School of Agricultural and Life Sciences,
The University of Tokyo
Dear Colleagues;
It is our great pleasure to announce that the annual meeting of the Japanese Society of Molecular Cell Biology of Macrophages (MMCB) will be held in Tokyo on June 9th and 10th, 2022 as a joint meeting co-organized with the Japanese Society of Interferon and Cytokine Research (JSICR). On behalf of the organizing committee, I would like to welcome your attendance at this joint meeting.
Because of the close relationship between MMCB and JSICR in terms of mutual personnel exchange and research interests, we once had a joint meeting between the two societies, organized by Prof. Kouji Matsushima held in Kanazawa in 2017. Based on that successful experience, the two societies will co-organize the annual meeting again in 2022 to aim for further fruitful collaboration in the research field of macrophages and cytokines.
In the past decade, the research field of monocytes, macrophages, and dendritic cells has progressed extensively. In particular, the understanding of macrophage diversity and their role and ontogeny has been greatly advanced in recent years. These findings will lead to the development of new treatments of cancer or autoimmune diseases in the near future. The main theme of this joint meeting is “New horizons in Immune-mediated homeostasis and diseases.”
This meeting will provide the attendees with a precious opportunity to discuss recent topics in both aspects of basic and clinical research.
Although COVID-19 has not gone away completely, the organizing committee expects the participation of as many people as possible, and fruitful discussion in this meeting.
Although COVID-19 has not gone away completely, the organizing committee expects the participation of as many people as possible, and fruitful discussion in this meeting.
Sincerely yours,
Masato Tanaka, MD., PhD
Chair, The 28th International Symposium on
Molecular Cell Biology of Macrophages (MMCB2022)
Laboratory of Immune Regulation,
School of Life Sciences,
Tokyo University of Pharmacy and Life Sciences
School of Life Sciences,
Tokyo University of Pharmacy and Life Sciences
